<DOC>
	<DOC>NCT01456455</DOC>
	<brief_summary>Descriptive registry to investigate frequency of HER-2 positive gastric cancer involving CNS. Exploration of additional prognostic factors for brain involvement from gastric cancer.</brief_summary>
	<brief_title>Gastric Cancer Metastasized to the Central Nervous System (CNS)</brief_title>
	<detailed_description>HER2 Status E-Cadherin Status</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Inclusion criteria: in order to be eligible for the study, the diagnosis of gastric cancer and/or lower esophageal cancer must be confirmed histologically. CNS involvement must be confirmed either via independent neuroradiological and/or positive CSF cytology. Exclusion criteria: Patients whose diagnosis is not confirmed upon pathological review or where the CNS involvement cannot be confirmed after neuroradiological review will be excluded from this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Central nervous system</keyword>
	<keyword>pathological markers</keyword>
</DOC>